Amerigen Pharmaceuticals

Sep 23, 2019

Amerigen to Commercialize Two of Inventia's ANDA's

May 08, 2019

Amerigen Announces U.S. FDA Approval For Generic Penicillamine 250 mg Capsules

Jan 24, 2019

Amerigen Announces U.S. FDA Approval For Generic Mixed Amphetamine Salts, Extended-Release Capsules

Jun 07, 2018

Amerigen Launches Generic Bexarotene Capsules

Mar 20, 2018

Amerigen Pharmaceuticals Limited today announced that its Abbreviated New Drug Application for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration

Jan 18, 2018

Amerigen's petition leads to U.S. Zytiga® patent invalidation

Oct 24, 2017

Amerigen and Biophore Collaborate on Penicillamine Generics

Sep 05, 2017

Amerigen believes that it is a first applicant to file an Abbreviated New Drug Application ("ANDA") for certain strengths of Namzaric® containing a "Paragraph IV" patent certification under the provisions of the Hatch-Waxman Act